At 10.9% CAGR, Asia Pacific Microbiology CRO Services Market is Projected to be Worth US$ 2,662.81 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the Asia Pacific microbiology CRO services market was valued at US$ 1,161.18 million in 2023 and is expected to reach US$ 2,662.81 million by 2031, registering a CAGR of 10.9% from 2023 to 2031. Advancements in microbiology testing technology and surging research and development investments are among the critical factors attributed to the Asia Pacific microbiology CRO services market expansion.

The advancements in microbiology testing technology have revolutionized the pharmaceutical and medical device industries. These advancements enable faster, more accurate, and cost-effective detection of microorganisms. A few critical advancements in microbiology testing technology are mentioned below:

• Molecular Diagnostics: Next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies have enabled rapid detection of microorganisms, allowing for earlier identification of contamination and reduced product recall rates.
• Automated Systems: Automated systems, such as microbiology analyzers and robotic systems, have increased efficiency, reduced labor costs, and improved accuracy in testing.
• Rapid Microbiological Methods: Techniques such as ATP bioluminescence, PCR-based methods, and mass spectrometry have accelerated microbial identification, reducing the time of results from days to hours or even minutes.
• Microbial Identification Systems: Advanced microbial identification systems such as matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry have improved accuracy and speed in identifying microorganisms.

The abovementioned advancements in microbiology testing technology have improved the accuracy, speed, and efficiency of testing. These improvements enable the pharmaceutical and medical device industries to reduce product recall rates, improve product quality, enhance patient safety, increase efficiency and reduce costs, and accelerate product development and launch timelines. This, in turn, has opened up new avenues for pharmaceutical companies to ensure the quality and safety of their products and for medical device manufacturers to ensure the sterility and biocompatibility of their devices. As a result, market players can invest in the latest microbiology testing technologies and develop new products and services that meet the evolving needs of industry. Thus, advancements in microbiology testing technology are expected to create new opportunities for the microbiology CRO market growth during the forecast period.

On the contrary, shortage of skilled professionals hampers the growth of Asia Pacific microbiology CRO services market.

Based on application, the Asia Pacific microbiology CRO services market is segmented into clinical, medical device, and others. The clinical segment held 50.2% share of the Asia Pacific microbiology CRO services market in 2023, amassing US$ 583.17 million. It is projected to garner US$ 1,385.11 million by 2031 to expand at 11.4% CAGR during 2023-2031.

Based on service type, the Asia Pacific microbiology CRO services market is segmented into assay development, custom viral stock production, microbial testing, and others. The microbial testing segment held 60.6% share of the Asia Pacific microbiology CRO services market in 2023, amassing US$ 703.19 million. It is projected to garner US$ 1,636.93 million by 2031 to expand at 11.1% CAGR during 2023-2031. 

Based on microorganisms, the Asia Pacific microbiology CRO services market is segmented into bacteria, fungi, viruses, and parasites. The bacteria segment held 43.2% share of the Asia Pacific microbiology CRO services market in 2023, amassing US$ 501.91 million. It is projected to garner US$ 1,190.70 million by 2031 to expand at 11.4% CAGR during 2023-2031.

Based on end user, the Asia Pacific microbiology CRO services market is segmented into biotech and pharmaceutical companies, medical device companies, and others. The biotech and pharmaceutical companies segment held 54.6% share of the Asia Pacific microbiology CRO services market in 2023, amassing US$ 633.43 million. It is projected to garner US$ 1,479.82 million by 2031 to expand at 11.2% CAGR during 2023-2031.

Based on country, the Asia Pacific microbiology CRO services market is segmented into China, Japan India, Australia, South Korea, and the Rest of Asia Pacific. China held 28.6% share of Asia Pacific microbiology CRO services market in 2023, amassing US$ 332.45 million. It is projected to garner US$ 808.97 million by 2031 to expand at 11.8% CAGR during 2023-2031.

Key players operating in the microbiology CRO services market are Microbiologics; Melbec Microbiology; Emery Pharma; TheraIndx Lifesciences Pvt. Ltd.; AVERIN BIOTECH; Statens Serum Institut; ImQuest BioSciences; PACIFIC BIOLABS; Innovotech Inc.; and BluTest Laboratories Ltd, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com